Caroline A. Kim, MD, MS; Suraj P. Rasania, MD; Jonathan Afilalo, MD, MSc; Jeffrey J. Popma, MD; Lewis A. Lipsitz, MD; Dae Hyun Kim, MD, MPH
Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health.
Grant Support: Dr. Caroline A. Kim was supported by the Health Resources and Service, Administration (D01HP08794) and a John A. Hartford Foundation Center of Excellence Award. Dr. Rasania was supported by the Health Resources and Services Administration (D01HP08794). Dr. Lipsitz was supported by the National Institute on Aging (R37-AG025037). Dr. Dae Hyun Kim was supported by The Medical Foundation, a division of Health Resources in Action (Charles A. King Trust Postdoctoral Fellowship Award) and the Harvard Catalyst, the Harvard Clinical and Translational Science Center, which received funding from the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (1KL2 TR001100-01) (KL2 Medical Research Investigator Training award).
Potential Conflicts of Interest: Dr. C.A. Kim: Grants (money to institution): Health Resources and Services Administration and John A. Hartford Foundation. Dr. Rasania: Grant (money to institution): Health Resources and Services Administration. Dr. Popma: Grants (money to institution): Medtronic, Boston Scientific, Cordis, Covidien, Abiomed, Cook, and Abbott Vascular; Personal fees: Boston Scientific, Cordis, Covidien, and Abbott Vascular. Dr. D.H. Kim: Grants (money to institution): National Institutes of Health and The Medical Foundation, a division of Health Resources in Action. All other authors have no disclosures. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M13-1316.
Requests for Single Reprints: Dae Hyun Kim, MD, MPH, Division of Gerontology, Beth Israel Deaconess Medical Center, 110 Francis Street, Suite 1B, Boston, MA 02215; e-mail, firstname.lastname@example.org.
Current Author Addresses: Drs. C.A. Kim, Lipsitz, and D.H. Kim: Beth Israel Deaconess Medical Center, 110 Francis Street, Suite 1B, Boston, MA 02215.
Dr. Rasania: Geisinger Medical Center, 100 North Academy Avenue, Danville, PA 17822.
Dr. Afilalo: Jewish General Hospital, 3755 Cote Sainte Catherine Road, Montreal, QC, Canada H3T 1E2.
Dr. Popma: Beth Israel Deaconess Medical Center, 185 Pilgrim Road, Boston, MA 02215.
Author Contributions: Conception and design: C.A. Kim, J.J. Popma, D.H. Kim.
Analysis and interpretation of the data: C.A. Kim, S.P. Rasania, J. Afilalo, J.J. Popma, L.A. Lipsitz, D.H. Kim.
Drafting of the article: C.A. Kim, S.P. Rasania, L.A. Lipsitz, D.H. Kim.
Critical revision of the article for important intellectual content: C.A. Kim, S.P. Rasania, J. Afilalo, L.A. Lipsitz, D.H. Kim.
Final approval of the article: C.A. Kim, J. Afilalo, J.J. Popma, L.A. Lipsitz, D.H. Kim.
Statistical expertise: D.H. Kim.
Administrative, technical, or logistic support: L.A. Lipsitz.
Collection and assembly of data: C.A. Kim, S.P. Rasania, D.H. Kim.
This article has been corrected. The original version (PDF) is appended to this article as a Supplement.
The functional and quality-of-life benefits of transcatheter aortic valve replacement (TAVR) have not been established.
To evaluate the changes in functional status and quality of life after TAVR.
MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials from 1 January 2002 to 30 September 2013.
Studies of TAVR that reported the New York Heart Association (NYHA) class, Short Form-12/36 Health Survey physical and mental component summary (points), or other measures of functional status.
Two reviewers independently extracted the mean change (follow-up minus baseline) in primary outcomes. Because of substantial heterogeneity, data were not pooled; the range of mean change was summarized.
We identified 60 observational studies (56 pre–post comparison and 4 head-to-head comparative studies) and 2 randomized, controlled trials (11 205 patients). Most studies showed a clinically important decrease in NYHA class at 6 to 11 months (range, −0.8 to −2.1 classes) and 12 to 23 months (range, −0.8 to −2.1 classes). The improvement in the Short Form-12/36 Health Survey physical component score was clinically important over 12 months (range, 4.9 to 26.9 points), and the change in mental component score was smaller (range, 1.0 to 8.9 points). Clinically important improvements were seen in other disease-specific measures but were less consistently seen in general health measures.
Comparative evidence is limited by few head-to-head studies. Survivor bias may have overestimated the benefits.
Transcatheter aortic valve replacement provides clinically important benefits in physical function and disease-specific measures of quality of life but modest benefits in psychological and general health measures. More comparative studies on functional status and quality of life are needed for informed treatment decision making.
Health Resources and Services Administration and Health Resources in Action.
Kim CA, Rasania SP, Afilalo J, Popma JJ, Lipsitz LA, Kim DH. Functional Status and Quality of Life After Transcatheter Aortic Valve Replacement: A Systematic Review. Ann Intern Med. 2014;160:243–254. doi: 10.7326/M13-1316
Download citation file:
Published: Ann Intern Med. 2014;160(4):243-254.
Cardiology, Valvular Heart Disease.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use